Jpmorgan Chase & CO Geo Vax Labs, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.1 Trillion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$0.3 - $0.57 $4 - $7
14 Added 43.75%
46 $0
Q3 2023

Nov 14, 2023
BUY
$0.51 - $0.62 $16 - $19
32 New
32 $0

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $69.3M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email